Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

584
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
584

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dopamine receptors in ocular surface biology: Current evidence and future directions.

Indian journal of ophthalmology·2026
Same author

Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy.

Indian journal of ophthalmology·2026
Same author

Long-term Outcomes of the Management of Chronic Refractory Ocular Allergy Using Allergen Immunotherapy.

Cornea·2026
Same author

Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease.

Investigative ophthalmology & visual science·2026
Same author

Biological cleansing: Toward improving ocular surface surgical outcomes.

Indian journal of ophthalmology·2026
Same author

Sesamol reprograms mitochondrial dysfunction and metabolic signaling to rescue endothelial degeneration in Fuchs' endothelial corneal dystrophy.

Free radical biology & medicine·2026

Related Experiment Video

Updated: Nov 25, 2025

Full-Field Optical Coherence Microscopy for Histology-Like Analysis of Stromal Features in Corneal Grafts
07:51

Full-Field Optical Coherence Microscopy for Histology-Like Analysis of Stromal Features in Corneal Grafts

Published on: October 21, 2022

1.8K

Biochemical Markers and Alterations in Keratoconus.

Rohit Shetty1, Sharon D'Souza1, Pooja Khamar1

  • 1Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)
|December 16, 2020
PubMed
Summary

Keratoconus (KC) is a progressive corneal thinning disease. Understanding its biochemical mediators is key to managing progression and developing targeted treatments for better patient outcomes.

More Related Videos

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.2K
Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.4K

Related Experiment Videos

Last Updated: Nov 25, 2025

Full-Field Optical Coherence Microscopy for Histology-Like Analysis of Stromal Features in Corneal Grafts
07:51

Full-Field Optical Coherence Microscopy for Histology-Like Analysis of Stromal Features in Corneal Grafts

Published on: October 21, 2022

1.8K
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.2K
Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.4K

Area of Science:

  • Ophthalmology
  • Corneal Diseases
  • Biochemistry

Background:

  • Keratoconus (KC) is a common corneal ectasia affecting younger populations, characterized by progressive thinning and steepening.
  • Its pathogenesis involves dysregulated extracellular matrix remodeling, but initiating factors remain unclear.
  • KC is multifactorial, influenced by genetics, environment, oxidative stress, and eye rubbing.

Purpose of the Study:

  • To investigate biochemical alterations in Keratoconus.
  • To identify key mediators contributing to KC pathogenesis and progression.
  • To explore potential therapeutic targets for improved disease management.

Main Methods:

  • Analysis of corneal tissues (epithelium, stroma), corneal fibroblasts/keratocytes, tear fluid, aqueous humor, and blood from KC patients.
  • Assessment of various biochemical factors including extracellular matrix components, cellular regulators, inflammatory factors, hormones, metabolites, and chemical elements.

Main Results:

  • Significant alterations in multiple biochemical factors were observed in KC subjects.
  • These biochemical changes are implicated in disrupting extracellular matrix remodeling dynamics (collagen deposition, degradation, cross-linking).

Conclusions:

  • Biochemical mediator alterations are central to Keratoconus pathogenesis.
  • Identifying these key mediators can aid in disease monitoring, progression prediction, and targeted therapeutic development.